Dedicated to Professor E. Wollenweber on the occasion of his 65 th birthday.
Botanical agents are widely perceived by the public as being both safe and effective alternatives to the pharmaceutical treatment of specific diseases. By virtue of their rich chemistry, complex botanicals are believed to offer enhanced efficacy via the inhibition of multiple pathologic pathways with decreased toxicity due to the low levels of individual compounds that are present. Scientific evidence in support of these concepts is limited in quantity and quality as the small number of available studies often use poorly characterized botanical products in regard to their chemical composition and biological activity [1] . Turmeric is one such dietary supplement whose proposed use in arthritis treatment stems from its traditional use as an anti-inflammatory botanical in Figure 1 : Chemical structures of three major curcuminoids in turmeric (curcumin (1), demethoyxcurcumin (2) , and bis-demethoxycurcumin (3)) Ayurvedic medicine. At the time that we began our investigations, little evidence was available regarding turmeric's efficacy as a treatment for arthritis [2] [3] [4] [5] ; no studies had demonstrated the mechanism of any potential anti-arthritic effect; and the comparative efficacy of well-characterized turmeric extracts and/or their fractions had not been reported. Results of our recently published translational arthritis studies [6, 7] , which addressed each of these issues utilizing well-characterized curcuminoid-containing turmeric extracts, will be summarized here.
Chemical and biological characterization of turmeric extracts
To investigate the anti-arthritic efficacy of turmeric, we either prepared or purchased turmeric extracts that were then chemically and biologically characterized prior to in vivo testing in an animal model of rheumatoid arthritis [6, 7] . a Although labeled as "98+% curcumin", this commercial product contained all three curcuminoids with total curcuminoid content < 98%.
[3]) ( Figure 1 and Table 1 ). Methanol extraction of a n-hexane marc yielded an essential oil-free fraction (3.1% yield) containing 41% curcuminoids (Table 1) . Because the anti-inflammatory efficacy of turmeric is often attributed to the ability of curcumin to inhibit prostaglandin production, the efficacy of these two complex turmeric extracts in preventing PGE 2 production was tested and compared to the effect of a commercial "curcumin" product demonstrated by HPLC to contain a 94% mixture of the three major curcuminoids (Table 1) .
Surprisingly, by this measure, the more complex crude extract and essential oil-free curcuminoid-containing fraction of turmeric appeared to be 10-fold more potent (as expressed either by total extract weight or by curcuminoid content) as anti-inflammatory agents than did the purified curcuminoids (Table 1 ). This finding suggests that components other than the three major curcuminoids present in the more complex turmeric extracts were acting in either a synergistic or additive fashion with the curcuminoids to inhibit PGE 2 production.
We next performed an HPLC analysis to determine the composition of randomly chosen turmeric products sold as botanical dietary supplements (n = 8) and available for over the counter sale in the United States [7] . Because curcumin is purported to be the active anti-inflammatory component in turmeric, most botanical supplements were reported to contain and/or be standardized to 95% curcumin or curcuminoids. However, the samples, which were all a mixture of the three major curcuminoids (2-34% curcuminoids by weight), contained on average only 47% of the reported amount of curcuminoids and were essential oil-free [7] . We therefore decided to focus our initial in vivo evaluation of turmeric's antiarthritic efficacy on our essential oil-free 41% curcuminoid-containing fraction of turmeric as this well characterized extract appeared most similar in composition to commercially available turmeric dietary supplements.
Anti-arthritic efficacy of curcuminoid fraction of turmeric
The animal model chosen for testing, streptococcal cell wall (SCW)-induced arthritis, is a wellcharacterized model of rheumatoid arthritis (RA) that mimics pathogenic and pathologic elements of RA in humans [8] [9] [10] [11] [12] [13] [14] . Repeated flares of joint inflammation ultimately lead to joint destruction in RA. In SCW induced arthritis, over a month long course of disease activity, an initial transient bout of joint inflammation is followed by a second chronic phase of joint swelling that is accompanied by actual joint destruction. In both RA and SCW-induced arthritis, the local production of inflammatory cell-attracting chemokines and joint-destructive inflammatory proteins by endothelial cells and joint lining cells (synoviocytes) that begin to proliferate in a tumorlike fashion drives disease activity.
Administration of the essential oil-free, curcuminoidcontaining fraction of turmeric (further referred to as curcuminoid fraction, CF) prevented SCW-induced joint swelling in a dose-dependent fashion throughout the month long course of disease activity (ID 50 of 12 mg curcuminoids/kg/d), inhibiting the actual onset of arthritis by a remarkable 80% at the highest dose tested (92% incidence in untreated vs. 18% incidence in treated) [7] . Delayed treatment with curcuminoid fraction was also effective in decreasing established joint swelling if begun soon after the onset of acute arthritis (34% inhibition, p < 0.05) [7] . However, as is commonly seen when testing drugs in animal models of RA [14, 15] , CF was less effective in ameliorating established arthritis than in preventing the onset of arthritis. Strikingly, even an isolated 4-day pretreatment with CF prior to injection with SCW prevented joint swelling over the one-month course of disease activity (47% inhibition, p < 0.05). Taken together, these findings suggested that CF treatment early in the course of joint inflammation is critical for preventing disease progression. CF was effective, not only in preventing joint inflammation
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Mechanism of anti-arthritic effect of curcuminoid fraction of turmeric
In vivo studies were then carried out to identify the mechanism of CF's protective effect in SCW-induced arthritis. Early treatment with CF prevented the activation of NF-κB within the joints (Figure 2 ), an effect that persisted through the month long course of disease activity [7] . NF-κB is a pivotal transcription factor in RA and other inflammatory diseases that is a key regulator of genes encoding the inflammatory proteins that mediate joint inflammation and destruction in RA [16] . Consistent with the Figure 2 . Effect of essential oil-free, curcuminoid-containing turmeric extract (curcuminoid fraction, CF) on NF-κB activation. Nuclear proteins from the hind paws of animals treated with vehicle alone, CF (23 mg curcuminoids/kg/d), SCW, or SCW + CF were isolated 3 days after SCW injection from n=3 paws/group and combined in equal amounts for analysis. Electrophoretic mobility shift assay of an unbound vs. proteinbound biotinylated DNA probe specific for NF-κB was then performed using 1 combined sample/treatment group. Specificity of NF-κB band was verified by competition with excess unlabeled NF-κB probe and by supershift of nuclear extracts incubated with antibodies directed against NF-κB p50 and p65 subunits (data not shown). Arthritis and Rheumatism (2006), 3452-3464, with permission.
inhibition of NF-κB activation, micro-array analysis of articular gene expression demonstrated CF inhibition of the transcription of key NF-κB regulated inflammatory gene products, including (1) chemokines that stimulated the influx of neutrophils and monocytes, (2) interleukin-1β, a key inflammatory cytokine in joint destruction and (3) COX-2, the inducible cyclooxygenase that stimulates inflammatory PGE 2 production (Table 3 ) [7] . Proof that decreased gene transcription led to decreased production of these inflammatory proteins was obtained by analysis of articular protein levels for these gene products [7] . The pathological significance of these findings was further confirmed by demonstrating an inhibition of neutrophil and monocyte influx, PGE 2 production, and cartilage and bone destruction by CF treatment [7] . Moreover, our demonstration of inhibitory effects of CF treatment on periarticular bone resorption and the major signaling pathway responsible for this [7] , RANKstimulated osteoclast formation and activity, are of particular interest since this same signaling pathway is responsible for bone loss in all resorptive bone diseases, including osteoporosis [17] [18] [19] . In summary, CF blocked several important signaling pathways that are also being targeted by pharmaceuticals under development for the treatment of inflammatory and metabolic bone disease [14, 16, 17] .
Comparison of anti-inflammatory effects of three curcuminoid-containing turmeric extracts
As previously alluded to, curcumin is believed to be the active anti-inflammatory component of turmeric [20] . Curcumin has been demonstrated in numerous in vitro studies to inhibit NF-κB activation and PGE 2 production [20] [21] [22] [23] . In many of these studies, the commercial products used were not characterized, but were most likely mixtures of the three major curcuminoids. It was, therefore, of interest to compare the in vivo efficacy of our CF to that of the 94% curcuminoid product (i.e. commercial, sciencegrade "curcumin"). To our surprise, while the purified curcuminoids were 10-fold less potent inhibitors of PGE 2 production in vitro, the opposite effect was seen in vivo for arthritis inhibition (Table  4) ; the purified curcuminoids were approximately 10-fold more potent in preventing joint inflammation than either the complex curcuminoid-containing turmeric fraction or the crude turmeric extract [6] . Thus, while in vitro biological screening assays are useful in ensuring extract reproducibility, one can see that the measurement of a botanical's effect on a single signaling pathway in one cell type does not necessarily translate into in vivo efficacy for a complex disease process, such as joint inflammation.
The problems inherent in using in vitro assays of biological assays to screen botanicals for potential in vivo activity is further demonstrated when one compares the effects of the three turmeric extracts (crude extract, essential oil-free curcuminoidcontaining fraction, and purified curcuminoids [Table1]) on a second inflammatory endpoint. In the SCW model, in addition to developing an RA-like inflammatory response at sites of SCW deposition in the joints, animals mount a granulomatous inflammatory response at sites of SCW deposition in liver and spleen [9] . In human disease, granuloma formation is a specific and useful biological response to certain invading pathogens, such as the bacillus causing tuberculosis (TB), which can be kept quiescent within the walls of reactive granulomas [24, 25] . In contrast, inappropriate granulomatous inflammation is the pathogenic basis of sarcoidosis, a potentially life-threatening non-infectious disease [25] . Interestingly, while purified curcuminoids were the most potent of the three turmeric extracts in preventing joint inflammation, they had absolutely no effect on the granulomatous inflammatory response (Table 4 ). In contrast, both the crude extract and essential oil-free curcuminoid fraction prevented granuloma formation (Table 4) . Thus, it would appear that components other than the three major curcuminoids that are present in the more complex turmeric extracts, while inhibiting the antiinflammatory effects of the three major curcuminoids in the joints, were able to act alone (or, potentially, in a synergistic or additive fashion with the curcuminoids) to inhibit the granulomatous inflammatory response.
These results demonstrate that the chemical complexity of botanicals translates into a very complex in vivo biological response. Moreover, they point out an inherent weakness in the postulate that botanicals, by their very complexity, offer more efficacy and less toxicity. Clearly, because the individual component of complex botanicals can each have independent effects on a specific disease process, the net effect of the sum of independent, additive, synergistic and/or opposing effects of each compound in a complex extract cannot be easily predicted, nor can the effects of a complex botanical on one disease process be extrapolated to another, even within the common realm of inflammation. Moreover, with regards to the potential toxicity of botanical extracts and the common assumption that complex extracts are inherently less toxic, it is also interesting to note that toxicity in these translational studies was inversely related to chemical complexity as mortality ranged from 0% with the purified curcuminoids, 6% with the CF and up to 24% with the crude extract [6, 7] .
Conclusion
In conclusion, these studies clearly demonstrate the anti-arthritic efficacy of well-characterized turmeric extracts in an animal model of RA and suggest the need for future clinical trials to verify efficacy in human disease. If one directly extrapolates the results of these trials to humans, one would predict that 1.5 g per day of purified curcuminoids might be the most potent and least toxic (including having the least risk of reactivating latent TB infections) turmeric treatment for RA [6, 7] . This dose would have to be given as a dietary supplement as dietary intake of curcuminoids only reaches 100 mg/d in countries with high dietary turmeric consumption [26] . In contrast, an even higher dose of a CF extract may hold promise in the treatment of granulomatous inflammation in sarcoidosis. However, our study results also clearly point out the need for careful clinical trials of turmeric extracts that are well defined in their chemical composition and biological activity.
While complex botanicals hold great promise for the treatment of specific diseases, their in vivo biological efficacy, in the final analysis, cannot be easily predicted but must instead, in each case, be directly tested. Moreover, the biological efficacy of botanicals can only be assured-and reproduced-by the use of well-characterized extracts.
